about
Assessing cost-effectiveness in the management of multiple sclerosis.Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus.Cost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.Economic burden in a German cohort of patients with multiple sclerosis.
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Health outcomes in multiple sclerosis.
@ast
Health outcomes in multiple sclerosis.
@en
type
label
Health outcomes in multiple sclerosis.
@ast
Health outcomes in multiple sclerosis.
@en
prefLabel
Health outcomes in multiple sclerosis.
@ast
Health outcomes in multiple sclerosis.
@en
P1476
Health outcomes in multiple sclerosis.
@en
P2093
Peter Flachenecker
Peter Rieckmann
P304
P356
10.1097/00019052-200406000-00004
P577
2004-06-01T00:00:00Z